Comparable graft survival is achievable with the usage of donation after circulatory death liver grafts from donors at or above 70 years of age: A long-term UK national analysis

Am J Transplant. 2021 Jun;21(6):2200-2210. doi: 10.1111/ajt.16409. Epub 2021 Jan 21.

Abstract

The aim of the study was to assess the UK donation after circulatory death (DCD) liver transplant experience from donors ≥70 years. Nationwide UK DCD retrospective analysis was conducted between 2001 and 2015 (n = 1163). Recipients were divided into group 1 vs. group 2 (donors 70≥ vs. <70 years, respectively). group 1 (n = 69, 5.9%) recipients were older (median 59 vs. 55 years, p = .001) and had longer waitlist time (128 vs. 84 days; p = .039). 94.2% of group 1 clustered in London and Birmingham, where the two busiest centers are located. group 1 allografts had higher UKDRI and UK DCD Risk Scores but similar WIT and CIT and were more likely to have been imported. Both groups had similar 1-, 3-, and 5-year graft survival (group 1, 90%, 81.4%, and 74% vs. group 2, 88.6%, 81.4%, and 78.6%, respectively; p = .54). Both groups had similar ICU stay length (p = .22), 3-month hepatic artery thrombosis rates (4.4% vs 4.0%; p = .9), and 12-month readmission rates for all biliary complications (20.3% vs 25.7%; p = .32). This study demonstrates that acceptable outcomes are achievable using older grafts in a highly selected cohort at experienced centers. Advanced age should not be an absolute contraindication to utilizing a DCD graft from donors aged ≥70 years.

Keywords: clinical research/practice; donors and donation: donation after circulatory death (DCD); donors and donation: extended criteria; liver transplantation/hepatology; organ acceptance; organ allocation; organ procurement; organ procurement and allocation.

MeSH terms

  • Aged
  • Brain Death
  • Death
  • Graft Survival*
  • Humans
  • Liver
  • Retrospective Studies
  • Tissue Donors
  • Tissue and Organ Procurement*
  • United Kingdom / epidemiology